Free Trial
OTCMKTS:CNTMF

Cansortium 4/30/2026 Earnings Report

Cansortium logo
$0.02 0.00 (0.00%)
As of 05/22/2026 03:58 PM Eastern

Cansortium EPS Results

Actual EPS
-$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
-$0.14

Cansortium Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cansortium Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cansortium Earnings Headlines

Vireo Growth to Acquire FLUENT in All-Stock Transaction
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
FLUENT Reports Fourth Quarter and Full Year 2025 Results
See More Cansortium Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cansortium? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cansortium and other key companies, straight to your email.

About Cansortium

Cansortium (OTCMKTS:CNTMF), Inc. (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.

Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.

Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets. The company has invested in high-intensity cultivation infrastructure and advanced manufacturing processes to ensure product consistency and supply reliability. Leadership is headed by CEO Daniel O’Connell, who has overseen the company’s growth strategy and digital retail initiatives.

View Cansortium Profile